Literature DB >> 15939534

HPV 16 E6 sequence variations in Indian patients with cervical neoplasia.

Narayanan Sathish1, Priya Abraham, Abraham Peedicayil, Gopalan Sridharan, George Chandy.   

Abstract

In a cross-sectional study performed between June 2001 and November 2003, the HPV 16 E6 gene of 50 women with cervical neoplasia and 20 cytologically normal women ('controls') was sequenced following amplification by PCR. The 350T to G variant was seen in 35 (70%) of 50 patients' isolates while it was seen in only 3 (15%) of the 20 isolates from the 'controls'. The higher occurrence of the 350G variant among the patients was statistically significant (P<0.01). Isolates from patients were grouped into the European (E), Asian-American (AA) and North-American (NA-1) phylogenetic clusters with 46 (92%) belonging to the E cluster. All the 20 isolates from 'controls' belonged to the E cluster. This study suggests an association of the HPV 16 350G variant with a higher risk of cervical neoplasia and a predominance of E lineage strains among Indian HPV 16 isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939534     DOI: 10.1016/j.canlet.2005.04.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Human papillomavirus 45 genetic variation and cervical cancer risk worldwide.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

2.  Genomic diversity and phylogenetic relationships of human papillomavirus 16 (HPV16) in Nepal.

Authors:  Robert Makowsky; Pema Lhaki; Howard W Wiener; Madhav P Bhatta; Michael Cullen; Derek C Johnson; Rodney T Perry; Mingma Lama; Joseph F Boland; Meredith Yeager; Sarita Ghimire; Thomas R Broker; Sadeep Shrestha
Journal:  Infect Genet Evol       Date:  2016-10-07       Impact factor: 3.342

3.  Genetic analysis of human papilloma virus 16 E6/E7 variants obtained from cervical cancer cases in Chhattisgarh, a central state of India.

Authors:  Sanjay Singh Negi; Kuldeep Sharma; Divakar Sharma; Pushpendra Singh; Pragya Agarwala; Nighat Hussain; Anudita Bhargava; Padma Das; Sarita Agarwal
Journal:  Virusdisease       Date:  2021-07-26

4.  Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Authors:  Ingeborg Zehbe; Christina Richard; Correne A DeCarlo; Anny Shai; Paul F Lambert; Hava Lichtig; Massimo Tommasino; Levana Sherman
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

5.  Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.

Authors:  Shailja Pande; Neeraj Jain; Bhupesh K Prusty; Suresh Bhambhani; Sanjay Gupta; Rajyashri Sharma; Swaraj Batra; Bhudev C Das
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

6.  Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Zigui Chen; Robert D Burk; Hugo De Vuyst; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

7.  HPV16 genetic variation and the development of cervical cancer worldwide.

Authors:  I Cornet; T Gheit; M R Iannacone; J Vignat; B S Sylla; A Del Mistro; S Franceschi; M Tommasino; G M Clifford
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

8.  Human papillomavirus type 16 E6 variants in France and risk of viral persistence.

Authors:  Iris Cornet; Tarik Gheit; Gary M Clifford; Jean-Damien Combes; Véronique Dalstein; Silvia Franceschi; Massimo Tommasino; Christine Clavel
Journal:  Infect Agent Cancer       Date:  2013-01-23       Impact factor: 2.965

9.  Sequence variation analysis of HPV-18 isolates in southwest China.

Authors:  Mengjie Shen; Xianping Ding; Tianjun Li; Gangyi Chen; Xiao Zhou
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.